MediXall Group, Inc.
MDXL · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $309 | $59 | $15 | $0 |
| % Growth | 422.1% | 295.3% | – | – |
| Cost of Goods Sold | $237 | $3,198 | $3,066 | $2,530 |
| Gross Profit | $73 | -$3,139 | -$3,051 | -$2,530 |
| % Margin | 23.6% | -5,296.2% | -20,349.5% | – |
| R&D Expenses | $0 | $39 | $0 | $0 |
| G&A Expenses | $3,989 | $5,841 | $6,398 | $5,308 |
| SG&A Expenses | $3,989 | $5,841 | $6,398 | $5,308 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $181 | -$17 | $624 |
| Operating Expenses | $3,989 | $59 | $6,381 | $5,932 |
| Operating Income | -$3,916 | -$6,540 | -$6,532 | -$5,932 |
| % Margin | -1,265.6% | -11,035.2% | -43,561.3% | – |
| Other Income/Exp. Net | -$647 | -$290 | $182 | -$624 |
| Pre-Tax Income | -$4,563 | -$6,830 | -$6,201 | -$5,932 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4,563 | -$6,830 | -$6,035 | -$5,932 |
| % Margin | -1,474.8% | -11,524.6% | -40,245.8% | – |
| EPS | -0.037 | -0.061 | -0.058 | -0.066 |
| % Growth | 38.9% | -5.7% | 11.6% | – |
| EPS Diluted | -0.037 | -0.061 | -0.058 | -0.066 |
| Weighted Avg Shares Out | 127,167 | 116,663 | 104,204 | 90,631 |
| Weighted Avg Shares Out Dil | 127,167 | 116,663 | 104,204 | 90,631 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $647 | $271 | $0 | $0 |
| Depreciation & Amortization | $34 | $36 | $4 | $4 |
| EBITDA | -$3,882 | -$6,524 | -$6,123 | -$5,928 |
| % Margin | -1,254.6% | -11,006.9% | -40,835.9% | – |